Nickan Research Institute Journal of Parathyroid Disease 2345-6558 11 1 2023 01 01 Cinacalcet in patients with secondary hyperparathyroidism; a review e11227 e11227 10.34172/jpd.2023.11227 EN Hamid Reza Hemmati https://orcid.org/0000-0002-9512-3120 Journal Article 10.34172/jpd.2023.11227 2023 05 25 2023 08 17 Secondary hyperparathyroidism is a common complication of chronic kidney disease characterized by excessive secretion of parathyroid hormone from the parathyroid glands. Cinacalcet is a calcimimetic medication that reduces parathormone levels by increasing the sensitivity of the calcium-sensing receptors on the parathyroid glands. This review aims to summarize the existing literature on the use of cinacalcet in patients with secondary hyperparathyroidism.